Electromedical's
Annual Cyber Sale
of Flagship Pain Relief Electrotherapy
Device
Set to Drive Year-End Revenue
-
Company routinely enjoys end-of-year bump in sales
-
Early indications suggest
solid demand for highly effective pain relief device
-
Current cyber special offering $300 discount runs through December
23rd
-
With $4.2 million in inventory, Electromedical setting stage for
major sales ahead
SCOTTSDALE, AZ -- December
15, 2020 -- InvestorsHub
NewsWire -- Electromedical Technologies,
Inc. (OTCQB:
EMED)
(the "Company"), a pioneer in the development and manufacturing
of bioelectronic
devices,
including the FDA cleared WellnessPro+,
is pleased to
announce that its annual product special offer
is generating solid demand and interest, which is typical of this
holiday season cyber campaign. The current cyber sale
includes a $300 discount off of the flagship WellnessPro+
price and
continues through December 23, 2020.
Electromedical
Technologies has roughly $4.2 million of the product in inventory
and management plans to sell most of its units during
this campaign and through future sales events. These
initiatives are ahead of the prospective launch of the
WellnessPlus
POD,
which is
currently under development. The WellnessPlus
POD
is positioned
as a
new, professional grade device for
retail customers that is smaller, has more features, and is
less
expensive than existing commercial
models.
Matthew Wolfson,
Founder and CEO of EMED, commented, "Every year we launch our
Cyber Monday promo, we enjoy a spike in sales. Demand and interest remain
solid thus
far this holiday season, aided by a meaningful $300 device
discount. With over 10,000 products
sold over
the years,
we are pleased to have helped our customers with relief from their
chronic pain through electrotherapy and
look forward to providing comfort and relief to many more
ahead. We
plan to engage in various campaigns to sell most of our remaining
products as we develop our new WellnessPlus
POD
and prepare for
its prospective launch late next year."
About Electromedical Technologies
Headquartered
in Scottsdale Arizona, Electromedical Technologies, Inc. is a
commercial stage, FDA cleared, bioelectronic
medical
device manufacturing company initially focused on the treatment of
various chronic, acute, intractable,
and
post-operative pain conditions. Through university collaboration
agreements the company is working to develop a comprehensive
research program in defining the effects of electro-modulation on
the human body by studying the impacts of electrical fields in cell
signaling and effects on virus assembly and immune responses with
the goal of improving human wellbeing. The company's current
cleared product indications are for chronic acute post traumatic
and post-operative, intractable pain relief.
Our
animal studies do not involve any human testing, and are not
related to our current products. We are conducting this research to
augment and advance the science of electro-modulation in
healthcare. The United States Food and Drug Administration
has not reviewed or approved our animal research studies
For
more information, visit
www.electromedtech.com.
Safe
Harbor Statement
This
release contains forward-looking statements that are based upon
current expectations or beliefs, as well as a number of assumptions
about future events. Although we believe that the expectations
reflected in the forward-looking statements and the assumptions
upon which they are based are reasonable, we can give no assurance
or guarantee that such expectations and assumptions will prove to
have been correct. Forward-looking statements are generally
identifiable by the use of words like "may," "will," "should,"
"could," "expect," "anticipate," "estimate," "believe," "intend,"
or "project" or the negative of these words or other variations on
these words or comparable terminology. The reader is cautioned not
to put undue reliance on these forward-looking statements, as these
statements are subject to numerous factors and uncertainties,
including but not limited to: adverse economic conditions,
competition, adverse federal, state and local government
regulation, international governmental regulation, inadequate
capital, inability to carry out research, development and
commercialization plans, loss or retirement of key executives and
other specific risks. To the extent that statements in this press
release are not strictly historical, including statements as to
revenue projections, business strategy, outlook, objectives, future
milestones, plans, intentions, goals, future financial conditions,
events conditioned on stockholder or other approval, or otherwise
as to future events, such statements are forward-looking, and are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. The forward-looking
statements contained in this release are subject to certain risks
and uncertainties that could cause actual results to differ
materially from the statements made.
Corporate Contact:
Electromedical
Technologies, Inc.
Matthew
Wolfson
Tel:
1.888.880.7888
email:
ceo@electromedtech.com
https://electromedtech.com
ElectroMedical Technolog... (PK) (USOTC:EMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
ElectroMedical Technolog... (PK) (USOTC:EMED)
Historical Stock Chart
From Sep 2023 to Sep 2024